ACELYRIN INC Common Valuation

SLRNDelisted Stock  USD 2.27  0.00  0.00%   
Based on Macroaxis valuation methodology, the entity appears to be overvalued. ACELYRIN INC Common shows a prevailing Real Value of $2.0 per share. The current price of the entity is $2.27. Our model approximates the value of ACELYRIN INC Common from evaluating the entity fundamentals such as current valuation of (175.46 M), and Price To Book of 0.56 X as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
2.27
Please note that ACELYRIN INC's price fluctuation is very steady at this time. Calculation of the real value of ACELYRIN INC Common is based on 3 months time horizon. Increasing ACELYRIN INC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ACELYRIN INC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ACELYRIN Stock. However, ACELYRIN INC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.27 Real  2.0 Hype  2.27 Naive  2.05
The intrinsic value of ACELYRIN INC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ACELYRIN INC's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.00
Real Value
2.50
Upside
Estimating the potential upside or downside of ACELYRIN INC Common helps investors to forecast how ACELYRIN stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ACELYRIN INC more accurately as focusing exclusively on ACELYRIN INC's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.272.272.27
Details
Hype
Prediction
LowEstimatedHigh
2.272.272.27
Details
Naive
Forecast
LowNext ValueHigh
2.052.052.05
Details

ACELYRIN INC Total Value Analysis

ACELYRIN INC Common is at this time projected to have valuation of (175.46 M) with market capitalization of 229.17 M, debt of 6.27 M, and cash on hands of . The negative valuation of ACELYRIN INC may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the ACELYRIN INC fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(175.46 M)
229.17 M
6.27 M

ACELYRIN INC Asset Utilization

One of the ways to look at asset utilization of ACELYRIN is to check how much profit was generated for every dollar of assets it reports. ACELYRIN INC Common shows a negative utilization of assets of -0.3 percent, losing $0.002982 for each dollar of assets held by the entity. Inadequate asset utilization signifies that the company is being less proficient with each dollar of assets it shows. Put another way, asset utilization of ACELYRIN INC Common shows how discouraging it operates for each dollar spent on its assets.

ACELYRIN INC Ownership Allocation

ACELYRIN INC holds a total of 100.95 Million outstanding shares. The majority of ACELYRIN INC Common outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in ACELYRIN INC Common to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in ACELYRIN INC. Please pay attention to any change in the institutional holdings of ACELYRIN INC Common as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.

ACELYRIN INC Profitability Analysis

Net Loss for the year was (248.23 M) with profit before overhead, payroll, taxes, and interest of 0.

About ACELYRIN INC Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of ACELYRIN INC Common. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ACELYRIN INC Common based exclusively on its fundamental and basic technical indicators. By analyzing ACELYRIN INC's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of ACELYRIN INC's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of ACELYRIN INC. We calculate exposure to ACELYRIN INC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ACELYRIN INC's related companies.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in ACELYRIN Stock

If you are still planning to invest in ACELYRIN INC Common check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACELYRIN INC's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance